{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:12:59Z","timestamp":1787008379510,"version":"build-2736575974"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>As Coronavirus disease 19 (COVID-19) has spread globally, hospital systems have seen an increasing strain on their ability to accommodate the growing caseload. This demand has led countries to adopt varying surge-facility or alternate care site (ACS) models to manage patient overflow. This report describes the experience of setting up pharmacy services at a city-run surge facility in Philadelphia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>The COVID-19 Surge Facility at the Liacouras Center (CSF-L) was initially developed to serve as a site for patients convalescing from acute inpatient stays in order to free up healthcare resources in surrounding hospitals. The CSF-L site required a distinct set of services to provide the desired level of care. This report details the preparations and challenges faced by the CSF-L pharmacy team in this endeavor, including identifying a pharmacy location that met regulatory requirements, obtaining proper licenses, coordinating drug procurement, filling staffing requirements, developing a formulary, defining the pharmacy and medication management workflow, and ensuring safety protocols were followed. This report explains the rational for developing certain processes and suggests alternative options and ideal plans for developing future pharmacy services in an ACS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Identifying a pharmacy leadership team early in the ACS planning process can lead to more efficient plans for pharmacy services. This report details the important steps taken, decisions made, and challenges faced in setting up pharmaceutical services at a COVID-19 field hospital.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajhp\/zxaa418","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T21:00:22Z","timestamp":1606942822000},"page":"416-425","source":"Crossref","is-referenced-by-count":7,"title":["Providing pharmacy services in a basketball arena: Reflections on building a pharmacy in a COVID-19 surge facility"],"prefix":"10.1093","volume":"78","author":[{"given":"Dillon","family":"Warr","sequence":"first","affiliation":[{"name":"Lewis Katz School of Medicine, Temple University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Storey","sequence":"additional","affiliation":[{"name":"Lewis Katz School of Medicine, Temple University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Denys","sequence":"additional","affiliation":[{"name":"Student and Employee Health Services, Temple University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Pennsylvania Hospital, Penn Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Rose","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Temple University School of Pharmacy, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,3]]},"reference":[{"issue":"10232","key":"2021021913175516200_CIT0001","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(20)30744-3","article-title":"Fangcang shelter hospitals: a novel concept for responding to public health emergencies","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet."},{"issue":"2","key":"2021021913175516200_CIT0002","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11096-020-01020-5","article-title":"Providing pharmacy services at cabin hospitals at the coronavirus epicenter in China","volume":"42","author":"Meng","year":"2020","journal-title":"Int J Clin Pharm."},{"key":"2021021913175516200_CIT0003","article-title":"Coronavirus hospitals in the field: how the Army Corps of Engineers fights COVID-19 with tents","author":"Loehrke","journal-title":"USA Today"},{"key":"2021021913175516200_CIT0004","author":"US Department of Health and Human Services","edition":"2nd edition"},{"issue":"19","key":"2021021913175516200_CIT0005","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/ajhp\/60.19.1993","article-title":"ASHP statement on the role of health-system pharmacists in emergency preparedness","volume":"60","year":"2003","journal-title":"Am J Health-Syst Pharm."},{"key":"2021021913175516200_CIT0006","author":"American Society of Health-System Pharmacists"},{"key":"2021021913175516200_CIT0007","author":"National Association of Boards of Pharmacy"},{"issue":"3","key":"2021021913175516200_CIT0008","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.japh.2020.04.006","article-title":"Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic","volume":"60","author":"Hua","year":"2020","journal-title":"J Am Pharm Assoc."},{"issue":"7","key":"2021021913175516200_CIT0009","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2146\/ajhp090659","article-title":"Pharmacist readiness roles for emergency preparedness","volume":"68","author":"Pincock","year":"2011","journal-title":"Am J Health-Syst Pharm."},{"issue":"4","key":"2021021913175516200_CIT0010","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1017\/dmp.2016.172","article-title":"Defining roles for pharmacy personnel in disaster response and emergency preparedness","volume":"11","author":"Alkhalili","year":"2017","journal-title":"Disaster Med Public Health Prep."},{"key":"2021021913175516200_CIT0011","article-title":"Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: a China perspective","author":"Zheng","year":"2020","journal-title":"Res Social Adm Pharm."},{"key":"2021021913175516200_CIT0012","author":"American Society of Health-System Pharmacists"},{"key":"2021021913175516200_CIT0013","volume-title":"WHO model list of essential medicines, 21st list","author":"World Health Organization"},{"key":"2021021913175516200_CIT0014","author":"The Joint Commission"},{"issue":"1","key":"2021021913175516200_CIT0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jama.2020.6016","article-title":"Ensuring access to medications in the US during the COVID-19 pandemic","volume":"324","author":"Alexander","year":"2020","journal-title":"JAMA."},{"key":"2021021913175516200_CIT0016","article-title":"SARS-CoV-2 outbreak: How can pharmacists help?","author":"Al-Quteimat","year":"2020","journal-title":"Res Social Adm Pharm."},{"issue":"16","key":"2021021913175516200_CIT0017","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMc2004973","article-title":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1","volume":"382","author":"van Doremalen","year":"2020","journal-title":"N Engl J Med."},{"issue":"3","key":"2021021913175516200_CIT0018","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.japh.2020.04.006","article-title":"Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic","volume":"60","author":"Hua","year":"2020","journal-title":"J Am Pharm Assoc."},{"key":"2021021913175516200_CIT0019","article-title":"Fighting against COVID-19: innovative strategies for clinical pharmacists","author":"Li","year":"2020","journal-title":"Res Social Adm Pharm."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxaa418\/34672707\/zxaa418.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/78\/5\/416\/36320850\/zxaa418.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/78\/5\/416\/36320850\/zxaa418.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T20:03:46Z","timestamp":1613851426000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/78\/5\/416\/6017469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,3]]},"references-count":19,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,12,3]]},"published-print":{"date-parts":[[2021,2,19]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxaa418","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3,1]]},"published":{"date-parts":[[2020,12,3]]}}}